This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
autonomous-vehicles: Archive
Adient Q1 Earnings Beat Expectations, Revenues Rise Y/Y
by Zacks Equity Research
Adient Q1 EPS beats estimates as revenues rise 4.3% year over year, with all three segments topping sales forecasts and fiscal 2026 guidance raised.
FNegative Net Change MODNegative Net Change ADNTNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings
After Golden Cross, Enterprise Financial Services (EFSC)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
EFSCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
How Is NIO Expanding Its Global Footprint Beyond China?
by Ashish Singh
NIO expands beyond China into Europe and Asia-Pacific, testing distributor-led EV growth.
NIONegative Net Change BYDDYNegative Net Change XPEVNegative Net Change
auto-tires-trucks autonomous-vehicles
Northwest Bancshares (NWBI)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
NWBINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Pathward Financial (CASH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CASHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
BYD Sales Slide in January Amid Rising EV Competition
by Zacks Equity Research
BYDDY's January 2026 NEV sales fall over 30% year over year, extending a five-month slide amid EV competition.
FNegative Net Change BYDDYNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles
Will Qualcomm's Next-Generation Snapdragon Elite Chip Fuel Its Shares?
by Zacks Equity Research
QCOM's Snapdragon Elite powers ECARX???s Zenith platform, advancing high-performance, software-defined vehicles with AI and safety features.
QCOMNegative Net Change NVDANegative Net Change NXPINegative Net Change ECXNegative Net Change
artificial-intelligence auto-tires-trucks autonomous-vehicles computers mobile semiconductor tech-stocks
Graco Inc. (GGG)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
GGGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tesla's Robotaxi Plans for 2026: Is Musk's Timeline Finally Realistic?
by Rimmi Singhi
TSLA's robotaxi rollout is accelerating in Austin and beyond, but after past delays, can Musk's 2026 autonomy timeline finally hold up?
AMZNPositive Net Change TSLANegative Net Change GOOGLPositive Net Change
autonomous-vehicles electric-vehicles self-driving-cars tech-stocks
Autoliv Q4 Earnings Surpass Expectations, Revenues Increase Y/Y
by Zacks Equity Research
ALV tops Q4 earnings and sales estimates as revenues rise 7.7% Y/Y, aided by new product launches.
FNegative Net Change ALVNegative Net Change PHINNegative Net Change
auto-tires-trucks autonomous-vehicles earnings